More than 50 peer-reviewed articles published in fiscal year 2024, bringing all-time number to nearly 450

KENNEDY SPACE CENTER, Fla., Jan. 9, 2025 /PRNewswire/ — The International Space Station (ISS) National Laboratory pushed scientific boundaries and set a record in scholarly output over the past year. Results from these investigations address real-world challenges and benefit Earth’s economy.

In fiscal year 2024 (October 1, 2023-September 30, 2024), more than 50 peer-reviewed articles related to ISS National Lab-sponsored research were published, bringing the all-time number to nearly 450. These findings lay a robust foundation for ongoing scientific advancements that promise significant benefits for humanity. Several groundbreaking results were featured in three new issues of Upward, official magazine of the ISS National Lab, highlighting the broad impact of research in space to improve the lives of people on Earth.

The following list details some of the most transformative investigations, underscoring their potential to drive further innovation and valuable applications.  

Top ISS National Lab-Related Scientific Results Highlighted in 2024

      1. Biomedical Advances: 3D Printing of Human Heart Tissue

Redwire Corporation utilized its BioFabrication Facility (BFF) on the ISS to 3D print live human heart tissue. This achievement moves us closer to producing complex human tissues in space to treat damaged tissue in people on Earth, potentially revolutionizing medical treatments for many conditions.

       2. Materials Science: Manufacturing Optical Fibers

Flawless Photonics produced more than 11 kilometers of ZBLAN optical fiber onboard the ISS, including a record-setting single pull that was more than a kilometer long. This production showcases the potential for creating superior optical fibers in microgravity, which could enhance telecommunications and medical technologies on Earth.

       3. Global Monitoring: Advanced Hyperspectral Imaging

Orbital Sidekick validated its cutting-edge hyperspectral imaging technology to monitor ecological changes and potential environmental disasters from space. This validation was a crucial step for the company to offer real-time global monitoring services that provide customers with a powerful tool to solve their most pressing challenges.

       4. Agricultural Innovations: Genetic Studies in Microgravity

Clemson University research into cotton genetics under microgravity conditions uncovered new methods to enhance crop resilience and productivity, with potential applications that could benefit global agricultural practices.

       5. Neurological Insights: Studying Brain Organoids

Axonis Therapeutics grew brain organoids in space to test a new therapeutic for neurological conditions like Alzheimer’s, Parkinson’s, and spinal cord injury. The ability to self-assemble brain organoids from mature cells in space in just a few days compared to months on Earth highlights the unique benefits microgravity offers for biological research.

       6. Educational Outreach: ISS Mimic by Creatorspace

ISS Mimic, an educational product developed by Creatorspace, allows students to build a 1:100 scale model of the ISS that mimics the real-time movements of the space station using actual telemetry data. This product aims to enhance science, technology, engineering, and mathematics (STEM) education in schools, libraries, and museums.

       7. Fluid Dynamics Research: Bubbles Behavior Study 

An experiment from researchers at the University of Notre Dame investigated the fluid dynamics of bubble formation in microgravity. The research sought to gain a better understanding of how bubbles form and grow to improve biosensors that could be used for early and asymptomatic cancer detection.

       8. AstroRad: A Wearable Radiation Shield 

Tested by crew members on the ISS, the AstroRad vest is designed to protect astronauts from radiation during missions to the Moon and Mars. Feedback from the tests led to design tweaks improving the vest’s fit and mobility, enhancing astronaut safety.

       9. Orbital Oncology: 3D Tumor Cell Cultures in Space

MicroQuin grew 3D cultures of breast and prostate cancer cells in microgravity to better understand cancer cell behavior. The findings provided significant insights into cancer cell survival mechanisms and could lead to a therapeutic to treat all types of cancer.

       10. Preventing Post-Traumatic Osteoarthritis: Tissue Chips Studies in Microgravity

A Massachusetts Institute of Technology (MIT) study explored the potential of utilizing tissue chips in space to better understand the underlying causes of post-traumatic osteoarthritis (PTOA). The findings provided valuable insights into the biological mechanisms of PTOA, potentially leading to innovative therapeutic strategies.

       11. Testing New Technology: Astrobee Robots on Station

NASA’s free-flying Astrobee robots on the ISS have assisted with more than 150 investigations, many of which were sponsored by the ISS National Lab. One such project tested specialized microphone technology designed to identify anomalies in equipment by interpreting changes in sound. Another tested a new method to rendezvous with tumbling objects in space for satellite recovery efforts. The Astrobees are also helping inspire the next generation of scientists through MIT’s Zero Robotics program.

Laying the Groundwork for Future Innovation 
Results from ISS National Lab-sponsored investigations reflect the value of leveraging the unique environment of space to conduct high-impact research that cannot be replicated on Earth. These efforts advance our understanding of fundamental science and drive innovations that address practical challenges across healthcare, technology development, and beyond.

For detailed information and behind-the-scenes stories on results from ISS National Lab-sponsored investigations, subscribe to Upward. 

Download a high-resolution image for this release: Nanoracks External Platform 

About the International Space Station (ISS) National Laboratory:
The International Space Station (ISS) is a one-of-a-kind laboratory that enables research and technology development not possible on Earth. As a public service enterprise, the ISS National Laboratory® allows researchers to leverage this multiuser facility to improve quality of life on Earth, mature space-based business models, advance science literacy in the future workforce, and expand a sustainable and scalable market in low Earth orbit. Through this orbiting national laboratory, research resources on the ISS are available to support non-NASA science, technology, and education initiatives from U.S. government agencies, academic institutions, and the private sector. The Center for the Advancement of Science in Space™ (CASIS®) manages the ISS National Lab, under Cooperative Agreement with NASA, facilitating access to its permanent microgravity research environment, a powerful vantage point in low Earth orbit, and the extreme and varied conditions of space. To learn more about the ISS National Lab, visit our website.

As a 501(c)(3) nonprofit organization, CASIS® accepts corporate and individual donations to help advance science in space for the benefit of humanity. For more information, visit our donations page.

View original content to download multimedia:https://www.prnewswire.com/news-releases/iss-national-lab-enables-record-breaking-year-of-space-based-scientific-results-302347261.html

SOURCE International Space Station National Lab

HUNTSVILLE, Ala., Jan. 9, 2025 /PRNewswire/ — healthŌme®, Inc., a pioneering genomics-based precision health management company, today announced its renaming and rebranding to Kadance, Inc. This transformative step embodies the company’s dedication to creating a seamless, DNA-powered health ecosystem that integrates advanced genomic insights with precision health solutions.

“Just as each of our members’ lives unfolds with unique rhythms, this rebrand marks a defining chapter for our company, aligning more closely with the distinct journeys of those we serve,” said Darren Rowe, CEO of Kadance. “This transformation highlights our focus on creating harmony between genetic insights and actionable precision health solutions. Kadance guides our members through key health moments while providing the support, commitment, and innovation they trust.”

Kadance: Purpose and Progress

Kadance represents more than a rebrand; it signifies a revitalized focus on offering accessible health management solutions supported by advanced technology and personalized human care. Kadance embodies the natural rhythm of life and health. As individuals navigate different stages of their health, Kadance provides living benefit services to guide members in making informed decisions throughout their health journey.

Name and Visual Identity: Precision and Connection

The Kadance name combines the concept of “cadence,” a steady and recognizable beat, with “dance,” which evokes movement and progression. Its distinctive “K” enhances its visual and phonetic uniqueness, making it stand out while reflecting the company’s innovative and evolving approach to personalized health management.

Kadance’s new visual identity reflects a commitment to innovation, connection, and care. The logo’s modern, streamlined design captures the brand’s forward-thinking approach, combining advanced genomics with personalized support to guide members throughout their lifetimes.

The bold Ember orange in the logo conveys energy and vitality, while the Marine accents provide a sense of trust and reliability. Together, they reflect Kadance’s dedication to integrating advanced genomic insights with personalized support, ensuring individuals can confidently and clearly navigate their unique health journeys.

The tagline “Proactive. Precise. Personal.” complements the logo and supports Kadance’s commitment to making precision medicine accessible while providing proactive genomic testing and tailored care. It reflects Kadance’s leadership in leveraging precision medicine to empower individuals with clear, actionable insights, enabling them to take control of their health with confidence.

Empowering Members With Genomics

“Kadance was created to help individuals take control of their health,” said Kim Scott, CCO of Kadance. “As health ebbs and flows, our solutions provide access to critically important genomic-based diagnostic tests and a support network of compassionate experts to interpret these results. Our members are armed with the genetic information their healthcare teams need to be able to provide precision healthcare. This is the future of customized health solutions—proactive, personal, and precise.”

Kadance redefines precision health management by delivering personalized solutions that empower individuals to make informed health decisions. Its offerings include proactive hereditary cancer risk testing, pharmacogenomic testing, and precision cancer management, which enable actionable visibility into hereditary cancer risk, optimized medication plans, and expert-led post-diagnostic services for more targeted treatment recommendations.

Kadance, with its fully integrated in-house genetics lab and partnerships with life and critical illness insurance carriers, delivers day-one living benefits, offering immediate value to members and keeping them engaged. By combining compassionate support with actionable genomic insights, Kadance makes precision health affordable and accessible to its members.

The rebranding is effective immediately, and the company has updated its digital presence to reflect this change. As the company moves forward, Kadance remains committed to simplifying healthcare navigation and improving lives through precision health management.

For more information, visit www.kadance.com and follow Kadance on LinkedIn for more updates.

About Kadance

Kadance is a genomics-based, precision health navigation company operating at the intersection of life insurance, life science, and health management. With a fully integrated, in-house genetics lab, Kadance is dedicated to simplifying and accelerating access to technologies and services that can dramatically alter an individual’s health trajectory, with an initial focus on cancer and pharmacogenomics. Kadance designs and delivers tech-enabled, precision health management solutions through a network of life and critical insurance carriers. Kadance and its subsidiary, Kailos Genetics, LLC, are based at the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama.

View original content to download multimedia:https://www.prnewswire.com/news-releases/healthme-inc-announces-rename-and-rebrand-as-kadance-inc-302347238.html

SOURCE Kadance, Inc.

Vivalink honored for enabling technology leadership with its innovative remote patient monitoring solutions

CAMPBELL, Calif., Jan. 9, 2025 /PRNewswire/ — Vivalink, a leading provider of digital healthcare solutions, receives Frost & Sullivan’s 2024 Global Healthcare IT Solutions Enabling Technology Leadership Award. This distinction highlights Vivalink as a leader in the global remote patient monitoring (RPM) market for worldwide clinical applications of hospital-at-home, cardiac monitoring and clinical trials.

Frost & Sullivan’s Enabling Technology Leadership Award recognizes companies that apply their technology in new ways to improve existing products and services and elevate the customer experience. Its primary criteria includes Vivalink’s leveraging of technology to improve efficiency, application diversity and creativity, as well as its customer impact through performance, customer experience and brand equity.

Vivalink’s medical-grade wearable technology enables providers to deliver patient-centered care for hospital-at-home services, ambulatory cardiac monitoring, and remote clinical trials. Unlike traditional RPM systems, Vivalink offers continuous, real-time monitoring for a variety of specialties, including cardiology, oncology and neurology, while supporting chronic condition management, early interventions, and specialized applications.

“Frost & Sullivan commends Vivalink for its strategic focus on addressing critical unmet needs and limitations within traditional remote patient monitoring systems, thus accelerating its leadership in the increasingly competitive space,” said Dr. Rishi Pathak, research director at Frost & Sullivan. “With its flexible, versatile, and scalable Biometrics Data Platform and unique business model, the company strategically positions its platform as a convenient, cost-effective, and advanced solution, helping Vivalink capture significant market share.”

This award highlights Vivalink’s commitment to innovation, creativity, and ability to launch new solutions with far-reaching impact and application. Through its evolving solutions, Vivlink enables the integration of RPM technologies for modern healthcare delivery and optimized patient care.

“It is an honor to be recognized as a global leader of health IT solutions, highlighting our commitment to providing informed, continuous data that drives modern healthcare delivery models,” said Jiang Li, PhD and CEO of Vivalink.

For a copy of the detailed award write-up, see: www.vivalink.com/HealthIT_Award

About Vivalink
Vivalink is a provider of digital healthcare solutions for remote patient monitoring in healthcare and clinical trials. By combining medical wearables, advanced algorithms, and clinical applications, we provide a more effective and accessible approach to patient care worldwide.

About Frost & Sullivan
Frost & Sullivan is the Growth Pipeline Company™. We power our clients to a future shaped by growth. Our Growth Pipeline as a ServiceTM provides the CEO and the CEO’s growth team with a continuous and rigorous platform of growth opportunities, ensuring long-term success. To achieve positive outcomes, our team leverages over 60 years of experience, coaching organizations of all types and sizes across 6 continents with our proven best practices. To power your Growth Pipeline future, visit Frost & Sullivan at http://www.frost.com.

Media Contact:
pr@vivalink.com

View original content:https://www.prnewswire.com/news-releases/vivalink-recognized-with-2024-global-healthcare-it-solutions-award-by-frost–sullivan-302347191.html

SOURCE Vivalink